Food and Drug Administration

Bilirakis Introduces Bipartisan Bill Improving Drug Development Against Rare Diseases

The fight against rare diseases has been slow due to several factors relating to regulations, something Representatives Gus Bilirakis (R-FL)…

2 weeks ago

New Controversy Over Uyghur Slave Labor Urges Rubio to Pressure White House Into Action

Despite the enactment of the Uyghur Forced Labor Prevention Act (UFLPA), which prohibits the importation of goods manufactured in the…

3 weeks ago

Congress Should Press for FDA Reform to Crack Down on Illegal E-Cigarettes

As a vape store owner and operator, I was glad to see the U.S. Senate Committee on the Judiciary press top…

4 months ago

Bilirakis, Scott Look to Accelerate Development of Treatments, Cures in Healthcare

Representative Gus Bilirakis (R-FL) – a senior member of the Health Subcommittee in the U.S. House of Representatives – and…

5 months ago

Senate Conservatives Concerned Over Controversial Abortion Drug’s Environmental Impact

Senate conservatives have expressed concern over potential adverse environmental impacts of increased abortion pill usage. The legislators are responding to…

6 months ago

Buchanan's MERIT Act Passes Important House Committee

Representative Vern Buchanan’s (R-FL) Mandating Exclusive Review of Individual Treatments (MERIT) Act has passed the House Energy and Commerce Committee…

1 year ago